Valuation: AstraZeneca PLC

Market Cap 267B 397,364B 234B 216B 199B 378B 25,478B 384B 2,575B 1,011B 12,551B 1,003B 981B 43,148B P/E 2026 *
21.5x
P/E 2027 * 18.9x
Enterprise Value 286B 425,919B 250B 231B 213B 405B 27,309B 412B 2,760B 1,084B 13,453B 1,075B 1,052B 46,249B EV / Sales 2026 *
4.53x
EV / Sales 2027 * 4.18x
Free-Float
96.63%
Yield 2026 *
1.94%
Yield 2027 * 2.05%

Last Transcript: AstraZeneca PLC

1 day-9.54%
1 week-15.84%
Current month-8.99%
1 month+0.60%
3 months-10.74%
6 months-6.56%
Current year-4.57%
1 week 67,050
Extreme 67050
75,900
1 month 64,925
Extreme 64925
80,275
Current year 64,925
Extreme 64925
80,275
1 year 43,950
Extreme 43950
80,275
3 years 17,537.5
Extreme 17537.5
80,275
5 years 4,760.5
Extreme 4760.5
80,275
10 years 214.5
Extreme 214.5
80,275
Manager TitleAgeSince
Chief Executive Officer 66 01/10/2012
Director of Finance/CFO 52 01/08/2021
Compliance Officer - 01/01/2023
Director TitleAgeSince
Director/Board Member 70 06/04/1999
Director/Board Member 66 01/10/2012
Director/Board Member 65 27/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
-9.54%-15.84% - - 267B
+0.13%-1.05%+48.56%+173.18% 1,060B
+0.32%-0.71%+64.20%+62.14% 619B
-0.69%-3.32%+28.61%+84.38% 438B
-1.69%+0.60%+29.53%+24.74% 333B
+0.27%-0.38%+29.23%+47.30% 282B
+0.67%+1.03%-26.81%-37.96% 218B
-2.01%-2.77%+19.96%+56.51% 196B
+0.16%+0.40%+16.09%+69.64% 161B
+1.10%+3.18%-3.45%-32.13% 138B
Average -1.12%-2.16%+22.88%+49.76% 382.73B
Weighted average by Cap. -0.81%-2.37%+35.41%+84.23%

Financials

2026 *2027 *
Net sales 63.22B 94,033B 55.29B 51B 47.11B 89.38B 6,029B 90.88B 609B 239B 2,970B 237B 232B 10,211B 66.8B 99,361B 58.43B 53.89B 49.77B 94.45B 6,371B 96.03B 644B 253B 3,138B 251B 245B 10,789B
Net income 12.43B 18,493B 10.87B 10.03B 9.26B 17.58B 1,186B 17.87B 120B 47.06B 584B 46.68B 45.66B 2,008B 13.94B 20,731B 12.19B 11.24B 10.39B 19.71B 1,329B 20.04B 134B 52.76B 655B 52.33B 51.19B 2,251B
Net Debt 19.2B 28,556B 16.79B 15.49B 14.3B 27.14B 1,831B 27.6B 185B 72.67B 902B 72.08B 70.51B 3,101B 11.95B 17,768B 10.45B 9.64B 8.9B 16.89B 1,139B 17.17B 115B 45.22B 561B 44.85B 43.87B 1,929B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
10/07/26 ARS 67,325.00 -9.54% 988
08/07/26 ARS 74,425.00 -1.85% 714
07/07/26 ARS 75,825.00 +1.57% 398
06/07/26 ARS 74,650.00 -6.69% 224
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
172.23USD
Average target price
212.94USD
Spread / Average Target
+23.64%

Quarterly revenue - Rate of surprise